Document is current
Any future updates will be listed below
-
Authors
Lorentzen, Eliza H.
Chen, Yu-Jen
Jones, Annabelle L.
Kantor, Olga
King, Tari A.
Mittendorf, Elizabeth A.
Minami, Christina A.
-
Funding
Funding for this research was provided by:
Brigham and Women’s Department of Surgery Hale Family Research Fellowship
Rob and Karen Hale Endowed Chair in Surgical Oncology
American Cancer Society Clinician Scientist Development Grant
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 7 May 2025
First Online: 20 May 2025
Declarations
:
: TAK reports speaker honoraria for Exact Sciences and compensated service on the FES Steering Committee, GE Healthcare; compensated service as faculty for PrecisCa cancer information service and compensated service on the advisory board for Veractye. EAM reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. All other authors report no disclosures or conflicts of interest.
